Litigation Details for Par Pharmaceutical, Inc. v. Amphastar Pharmaceuticals, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Par Pharmaceutical, Inc. v. Amphastar Pharmaceuticals, Inc. (D. Del. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-12-20 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 9,375,478; 9,687,526; 9,744,209; 9,744,239; 9,750,785; 9,937,223 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Par Pharmaceutical, Inc. v. Amphastar Pharmaceuticals, Inc.
Details for Par Pharmaceutical, Inc. v. Amphastar Pharmaceuticals, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-12-20 | 1 | United States Patent Nos. 9,375,478 (“the ‘478 Patent”), 9,687,526 (“the ‘526 Patent”), 9,744,209 (“…(“the ‘209 Patent”), 9,744,239 (“the ‘239 Patent”), 9,750,785 (“the ‘785 Patent”) and 9,937,223 (“the…the ‘223 Patent”) (collectively, “the Patents-in-Suit”). This action is based upon the Patent Laws of … The Patents-in-Suit 14. On June 28, 2016, the United States Patent and Trademark…copy of the ‘478 Patent is attached as Exhibit A. Par Pharmaceutical owns the ‘478 Patent. 15. | External link to document | |
2018-12-20 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,375,478 B1 ;US 9,687,526 …December 2018 1:18-cv-02032-CFC 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |